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Abstract 
 Objective: To determine the prevalence of coronary artery disease in 
patients undergoing valve surgery for rheumatic heart disease between age 
40-50 years, usefulness, and indication of pre-operative coronary 
angiography. Methods: This is an observational prospective study that took 
place in 2 hospitals (National Heart Institute and Nasser Institute) within the 
period starting from January 2013 to January 2015. We included 454 
rheumatic patients that were admitted for elective primary mitral, aortic or 
double valve surgery, and that had a coronary angiogram in their regular pre-
operative workup. All coronary angiographies were performed by injecting 
right and left coronaries by using 80-100 ml of iodinated contrast to obtain 
the standard views of both right and left coronaries using Philips or Siemens 
machines in both hospitals. Coronary artery disease (CAD) of 50% is 
considered to be a positive finding. Results: There was no correlation 
between rheumatic heart disease in this age group and CAD as only 1.76% 
had the significant stenosis. Male gender, family history of CAD, age above 
45yrs, hypertension, and smoking showed significant correlation with the 
CAD in this study. Conclusion: Our results suggest that the overall 
prevalence of coronary artery disease in patients undergoing rheumatic valve 
surgery in our population is not comparable with the prevalence reported in 
international data. So, multicenter studies are needed in developing countries 
to set their own guidelines. Therefore, our study can be the nucleus for these 
guidelines in our country. 
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Introduction 
 Valvular heart disease is a growing problem, particularly in developing 
countries. It is important to consider that the spectrum of valve disease in the 
developing world is different from that of developed countries. The 
predominant pathology of valve disease in our patients is rheumatic, whereas 
degenerative valve disease is the predominant one in the west. Rheumatic 
heart disease is a major health issue in developing countries with an incidence 
of over 1 per 1000 people (David, 1995). In children and young adults, it is 
the commonest form of valvular disease that requires surgery (Markus et al., 
1994). 
 Guidelines of the American College of Cardiology (ACC)/American 
Heart Association (AHA) recommended that a coronary angiography should 
be performed before valve surgery in men aged >35 years, women aged >35 
years with coronary risk factors, and in post-menopausal women (Bonow et 
al., 2008). However, these guidelines may not be applicable to all our patients 
as coronary artery disease is not the prevalent heart problem in developing 
countries.  
 The aim of our study is to determine an overall prevalence of CAD in 
patients undergoing rheumatic valve surgery between ages 40-50 years and to 
what extent pre-operative coronary artery angiography as an invasive 
diagnostic form is needed. 
 
Patients and Method 
 454 consecutive preoperative patients aged from 40- 50 years, who had 
rheumatic valvular heart disease at National Heart Institute and Nasser 
Institute from January 2013 to January 2015, were prospectively studied to see 
the incidence of significant coronary artery disease-among them by 
performing preoperative elective coronary angiography as per SCC/ AHA 
guidelines (Bonow et al., 2008). 
 Patients who need emergent valve replacement surgeries were not 
delayed for assessment of coronary anatomy. Also, they were excluded from 
the study as per hospital protocol; similarly, patients with a history of prior 
revascularization were also excluded. 
 All coronary angiographies are performed by injecting right and left 
coronaries by using 80 -100 ml of iodinated contrast to obtain the standard 
views of both right and left coronaries (AP (0) caudal (30), AP (0) cranial (30), 
LAO (50) cranial (30), LAO (50) caudal (30), RAO (20) caudal (20), RAO 
shallow cranial, left lateral view for left coronary system, and LAO 30, RAO 
30, PA cranial for right coronary artery) using Philips (DICOM viewer 
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software) or Siemens (Artis one, Sango Angio package software) machines in 
both hospitals. Coronary artery disease (CAD) of 50% is considered to be a 
positive finding. All coronary angiograms were performed and reported by 
well trained and experienced cardiologists. Concomitant coronary artery 
bypass surgery was added to the valvular surgery on the basis of coronary 
anatomy.  
 In this study, diabetes mellitus is defined as fasting glucose >126 
mg/dl, hyperlipidemia as cholesterol > 200 mg/dl or on treatment, 
hypertension as blood pressure >140/90 mmHg. On the other hand, due to 
treatment, family history of coronary artery disease such as any first degree 
that is relative had received anti-ischaemic drug, history of chest pain, 
previous catheterization or stenting for coronaries, or ICU admission for 
myocardial infarction and obesity as BMI> 30. An echocardiogram was 




 A total of 454 patients were enrolled prospectively in this study. The 
demographic criteria of them are shown in Table 1. The mean age was 45.152 
years. 254 (55.9%) were females while 200 (44.1%) were males. 109 (24%) 
patients had aortic valve surgery for aortic stenosis, while 35 (7.7%) patients 
had aortic valve surgery for aortic regurgitation. 297 (65.4%) patients with 
mitral stenosis had mitral valve surgery, while 100 (22%) patients with mitral 
regurgitation had mitral valve surgery. It was noted that 87 (19.2%) of these 
patients had double valve disease, 23 (5.1%) of these patients had diabetes 
mellitus, 24 (5.3%) were hypertensive, 19 (4.2%) were smokers, 36 (7.9%) 
were obese, 4 (0.9%) had hyperlipidemia, and 9 (2%) had a positive family 
history of coronary artery disease (CAD) (see Figure 2). 
Table 1. Demographic criteria of the study group 
Table 1    
 n % P 
40-45 years 1 12.5 
0.023 
46-50 years 7 87.5 
Female 0 0 
0.001 
Male 8 100 
Diabetes Mellitus 1 12.5 0.333 
Hypertension 2 25 0.012 
Smoking 2 25 0.003 
Obesity 1 12.5 0.629 
Hyperlipidemia 0 0 0.788 
Family History of CAD 2 25 0 
n: number; %: percentage; p: predictive value 
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 The results showed that from the 454 patients, 8 (1.76%) had >50% 
coronary stenosis (see Figure 1). 1 (12.5% of all CAD) (0.2% of whole 
sample) patient were aged 40 – 45 years, while 7 (87.5% of all CAD) (1.5% 
of whole sample) patients were aged 46 – 50 years (p = 0.023). 8 (100% of all 
CAD) (1.76% of whole sample) were males, while none (0%) were females (p 
= 0.001). 1 (12.5% of all CAD)  (0.23% of whole sample) had diabetes 
mellitus (p = 0.333). 2 (25% of all CAD) (0.46% of whole sample) were 
hypertensive (p = 0.012). 2 (25% of all CAD) (0.46% of whole sample) were 
smokers (p = 0.003). 1 (12.5% of all CAD) (0.23% of whole sample) was 
obese (p = 0.629). None (0%) of the patient had hyperlipidemia (p = 0.788). 
2 (25% of all CAD) (0.46% of whole sample) had a positive family history of 
CAD (p = 0.12) (see Table 1). Distribution of coronary artery disease among 
different rheumatic lesions is shown in Table 2. 5 (62.5% of all CAD) (1.1% 
of whole sample) patients had mitral stenosis (p = 0.861), while 1 (12.5% of 
all CAD) (0.23% of whole sample) patient had mitral regurgitation (p = 
0.521). 4 (50% of all CAD) (0.88% of whole sample) patients had aortic 
stenosis (p = 0.082), while none (0%) had aortic regurgitation (p = 0.410). 6 
(75% of all CAD) (1.3% of whole sample) patients had single valve disease, 
while 2 (25% of all CAD) (0.46% of whole sample) patients had double valve 
disease (p = 0.965) (see Table 2).  
Table 2. Distribution of coronary artery disease among different rheumatic lesions 
Table 2    
 n % P 
SVD 6 75 
0.965 
DVD 2 25 
MS 5 62.5 0.861 
MR 1 12.5 0.521 
AS 4 50 0.082 
AR 0 0 0.410 
n: number; %: percentage; p: predictive value; SVD: single valve disease; DVD: double 
valve disease; MS: mitral stenosis; MR: mitral regurgitation; AS: aortic stenosis; AR: 
aortic regurgitation 
 
 However, the outcome of the previous results showed no correlation 
between rheumatic heart disease in this age group and significant coronary 
artery stenosis. Thus, only 1.76 % had coronary stenosis. Male gender, family 
history of CAD, age above 45 years, hypertension, and smoking showed 
significant correlation with the coronary artery stenosis in this study as shown 
in Figure 2. 
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Figure 1. Incidence of CAD in patients’ sample 
 
 
Figure 2. Incidence of significant risk factors in rheumatic patients with CAD 
 
Statistical Methods 
 Recorded data were analyzed using the statistical package for social 
sciences, version 20.0 (SPSS Inc., Chicago, Illinois, USA). Quantitative data 
were expressed as the mean ± standard deviation (SD). Qualitative data were 
expressed as frequency and percentage. The following tests were done: Paired 
sample t-test of significance was used when comparing between the related 
sample; Chi-square (X2) test of significance was used in order to compare 
proportions between two qualitative parameters; the confidence interval was 
set to 95% and the margin of error accepted was set to 5%. So, the p-value was 
considered significant as follows: Probability value (P-value) <0.05 was 
considered significant, P-value <0.001 was considered to be highly significant, 
and P-value >0.05 was considered insignificant. 
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Comment 
 Guidelines for preoperative CA in patients with VHD undergoing 
valvular surgery are primarily based on studies where the majority of the 
patients had degenerative VHD (Bonow et al., 2008). There is no distinction 
between rheumatic valvular heart disease and degenerative valvular heart 
disease in this matter. Moreover, the incidence of CAD in patients undergoing 
valve surgery had been shown to vary widely from 9% to 41 % (Sonmez et 
al., 2002). In addition, we should strongly consider the fact that the majority 
of these patients are elderly, and they have degenerative valve disease and 
multiple coronary risk factors. However, in Egypt and other developing 
countries where the major aetiology of VHD is rheumatic, the prevalence of 
coexistent CAD is much lower as compared to western patients (Jose et al., 
2004; Kruczan et al., 2008). 
 In this series, the overall prevalence of CAD in all rheumatic groups 
was 1.76%, which is much lower than that of the western population (16% to 
50%) according to some authors (Bonow et al., 2006; Silaruks et al., 2001; Li 
et al., 2007; Shaikh et al., 2011). It is also much lower from studies done in so 
many developing countries. Only one study from Spain done by Rangel et al. 
showed the prevalence of 8%. In South East Asian countries like China, the 
prevalence was found to be 11% (Bozbaş et al., 2004), but in Pakistan, it was 
on higher side 31.3% (Rangel et al., 1996). In some Indian studies, the 
prevalence was found between 7% and 12% (Paradis et al., 2013; Atalar et al., 
2012; Lim et al., 2003). Saharia and Devi (2016) analyzed CA of 100 patients 
with rheumatic valvular disease and reported the prevalence of significant 
CAD to be 14%.  Shaikh et al. (2011) reviewed medical records of 144 patients 
and found CAD in 25% patients of RHD. Two studies from India by Jose et 
al. (2004) and Narang et al. (2009) have reported the prevalence of CAD to be 
12.2% and 11% respectively in patients with RHD undergoing valve surgery. 
Kruczan et al. (2006) in their study of 294 patients with rheumatic and non-
rheumatic VHD reported that patients with rheumatic VHD had a lower 
prevalence of CAD (4%) when compared to those with non-rheumatic VHD 
(33.61%). 
In their study, Saharia and Devi (2016) stated that coronary 
angiography was performed in patients over the age of 50 years, those having 
angina or ECG signs of ischemia, which can explain the higher prevalence. 
However, in the study of Shaikh et al. (2011), the relatively high incidence of 
CAD (25% patients of RHD) can be attributed to a very high incidence of DM, 
hypertension, and dyslipidemia in their study population and the elderly as 
well. Consequently, the range of age for patients with regards to CAD risk 
factors was not specified in the study of Narang et al. (2009) as well as the 
symptoms. 
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 Kruczan et al. (2006), in their study of 294 patients with rheumatic and 
non-rheumatic VHD, reported that patients with rheumatic VHD had a lower 
prevalence of CAD (4%) when compared to those with non-rheumatic VHD 
(33.61%). The prevalence of CAD (4%) in this study is still higher than our 
study (1.76%). In addition, this higher incidence can be attributed to a higher 
frequency of male sex and older age.  
 The hypothesis of rheumatic fever that can cause arteritis in 
intramyocardial coronaries is yet to be proven. Even more, the actual 
prevalence of CAD in RHD patients is not more than that of the general 
population (Manjunath et al., 2014). However, there are so many factors that 
can play a significant role in the variation of the incidence of CAD in 
rheumatic populations and between different countries. For example, the 
higher age group in the Western countries and different sample sizes. It also 
entails the demographic, clinical, and environmental characteristics of the 
different populations such as race, dietary habits, and physical activity. 
 In regards to the male to female ratio, it is given as 1.27:1 in our study, 
and it is matched with 1.86:1 of Choudary study in 2016 (Choudhary et al., 
2016). Also, some other studies showed ratio between 1.6:1 and 2.6:1 (Sonmez 
et al., 2002; Li et al., 2007; Rangel et al., 1996). Furthermore, only one study 
from China done by Li et al. showed a ratio of 3:1 (Li et al., 2007). The mean 
age of RHD patients who had CAD was 52.8 ± 8.6 years (52.3 ± 8.9 for males 
and 53.6 ± 8 for females) in Choudary study (Choudary et al., 2016). In Nikhil 
study (Nikhil et al., 2016), it was 55.2±8.65 years. The mean age of CAD in 
RHD patients was around 55–60 years in Western and Chinese studies (Li et 
al., 2007; Bozbaş et al., 2004; Paradis et al., 2013) when compared to other 
Indian studies (Jose et al., 2004; Narang et al., 2009; Gupta et al., 1990) and a 
study from Pakistan (Shaikh et al., 2011). In our study, we investigated one 
age group of 40-50 years and, probably, this is one of the reasons why we had 
a low overall incidence of CAD in our cohort. 
 The SVD and DVD were found in 6 patients (75% of all CAD) (1.3% 
of the whole sample). 2 patients (25% of all CAD) (0.46% of whole sample) 
had double valve disease respectively (p = 0.965) opposite to 55.1% of CAD 
and 29% of CAD in Nikhil study respectively (Nikhil et al., 2016). Moreover, 
Left anterior descending was the most common vessel involved (overall 
63.7% and 30.4% in isolated cases) followed by LCX (51%) and RCA (35.7%) 
in Nikhil’s study. Rangel et al. (1996) and Li et al. (2007) also found that LAD 
was the most commonly involved artery followed by RCA and LCX. Also, we 
did not report frequency and distribution of the involved coronaries or their 
occurrence with individual rheumatic valve disease because we believe that 
their occurrence with them is causal and has no specific relation. 
 Furthermore, there are modifiable and non-modifiable risk factors for 
CAD. The most important of which is Hypertension, smoking, DM, family 
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history of CAD, post-menopausal females, and old age. Most authors who 
investigated this matter looked at these factors thoroughly. A prospective 
study using multimarker strategy showed a higher predictivity of CAD risk 
factors in rheumatic valve patients (Narang R, 2009). Another study reported 
a higher incidence of HTN, smoking, DM, and dyslipidemia in RHD patients 
having CAD than those without CAD (Gupta et al., 1990). Same risk factors 
were found to be strong predictors of CAD in some studies (Lin et al., 2001; 
Silaruks et al., 2001). Lin et al. (2003) and Lim et al. (2001) found that the 
incidence of CAD in the two models was 19.3% and 36% respectively. This, 
however, means a low incidence of CAD in rheumatic patients. Therefore, the 
strength of prediction and the respective relationship between predictors 
derived in previous analyses might be lost. Unfortunately, we did not report 
patients symptomatology as such, but most authors reported a strong 
association between angina as a predictor and CAD in rheumatics (Kruczan et 
al., 2008; Paradis et al., 2013; Silaruks et al., 2001). 
 In line with other studies (Jose et al., 2004; Kruczan et al., 2008; Guray 
et al., 2004), our study reports a low incidence of CAD (1.75%) in the 
rheumatic patients. Nikhil et al. (2016) stated that antibiotic prophylaxis, with 
its proposed anti-inflammatory effect against coronary atherosclerosis, is a 
remote explanation for the low incidence of CAD because his patients rarely 
had this prophylaxis. Kruczan et al. (2008), on the other hand, concluded that 
the low prevalence could be due to the demographic and clinical 
characteristics. Again, we believe that the main reason why our incidence of 
CAD is low is that the age group that we elected to investigate is only 40-50 
years and the incidence of CAD in older rheumatics may be higher. Moreover, 
we accept the theory of different demographic, clinical, and environmental 
characteristics as well as dietary, smoking habits, and race as a reason for the 
variable incidence of CAD in rheumatic population.  
 In our series, Mitral valve was involved in 75% of RHD patients with 
CAD, aortic valve in 50% of them, and DVD was involved in only 25% of 
them. This perfectly matches with what had been found by some authors 
(Nikhil et al., 2016) (66.1% mitral, 7.3% aortic and both valves in 26.6%). In 
agreement with our findings, Shaikh et al. (2011), just like us, also reported a 
higher incidence of mitral valve involvement than the aortic and double valve 
involvement in RHD patients with CAD. This can be attributed to the high 
prevalence of mitral valve disease in RHD patients. 
 In our cohort, the incidence of CAD in regurgitation lesions was very 
low (one patient only 12.5% who had MR) in comparison with stenotic lesions 
(100% of the sample almost half by half MS and AS). This is in concordant 
with the study of Nikhil et al. (2016) that showed a significant inverse 
association between MR and prevalence of CAD (P = 0.005) based on 
univariate analysis. On the other hand, Narang et al. (2009) showed a 
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significant inverse association between AR and CAD, and there was no 
significant association between MR and CAD. Other authors found the same 
association of stenotic lesions and CAD (Sonmez et al., 2002; Narang et al., 
2009). Therefore, we can conclude that the stenotic lesions of both mitral and 
aortic rheumatic valves are more likely to be associated with CAD than the 
regurgitation lesions. The reason for this can be a more prolonged and ongoing 
inflammatory process responsible for stenotic lesion, leading to microvascular 
changes and endothelial dysfunction (Nikhil et al., 2016). Though it is not a 
solid conclusion, we need more studies to prove or disprove it. 
 Finally, it is interesting to state that only rheumatic males had 
significant CAD in our cohort as compared to females. Also, CAD was found 
only in patients with major coronary risk factors namely: age >45 years, 
hypertension, family history, and smoking. Thus, it can be inferred that in this 
subset of patients, preoperative coronary angiography can be considered only 
in the presence of multiple coronary risk factors or symptoms suggestive of 
CAD, or if there is a high clinical likelihood of CAD.  
 
Conclusion 
 In this age group, the rheumatic valvular disease shows no correlation 
with coronary artery disease. All of the coronary artery disease patients were 
males, with CAD risk factors of family history, hypertension, and smoking. 
Thus, any female below the age of 45 with no risk factor should not undergo 
a routine preoperative coronary angiography.  Moreover, our results suggest 
that the overall prevalence of coronary artery disease in patients undergoing 
rheumatic valve surgery in our population is not comparable with the 
prevalence reported in international data. As a result, multicenter studies are 
needed in developing countries to set their own guidelines, and our study can 
be the nucleus for these guidelines in our country. 
 
List of abbreviations 
CAD: Coronary Artery disease; RHD: Rheumatic Heart Disease; LAD: 
Left Anterior Descending; LCx: Left Circumflex; RCA: Right Coronary 
Artery; CA: coronary angiography; AP: antero-posterior; LAO: left anterior 
oblique; RAO: right anterior oblique; DM: diabetes mellitus; ICU: intensive 
care unit; CABG: coronary artery bypass grafting; BMI; body mass index; 
SVD: single valve disease; DVD: double valve disease; VHD: valvular heart 
disease; MS: mitral stenosis; MR: mitral regurgitation; AS: aortic stenosis; 
AR: aortic regurgitation. 
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